01/27/23 11:31 AMNasdaq : TRIB low floatAris Kekedjian, Former Icahn CEO, and Stanford University’s Dr. Yossi Feinberg Headline Panel on How Leaders Can Preserve Corporate Value Amid Economic RisksMr. Kekedjian and Dr. Feinberg offer a fresh take on hedging risks and proven strategies that leverage innovation during the interactive panel, allowing for questions from the audience. Mr. Kekedjian brings a wealth of global leadership and strategic transformation experience to this timely discussion, having previously served as Head of Business...RHEA-AIneutral
01/25/23 3:00 PMNasdaq : TRIB low floatHome-Based Devices to Revolutionize the Lateral Flow Assays Market, The Market to Cross USD 11 Billion by 2028 - AriztonAccording to Arizton's latest research report, the lateral flow assays market will grow at a CAGR of 3% from 2023-2028. Smartphone and AI integration in lateral flow immunoassay, evolving new applications of lateral flow assays, and a surge in demand for lateral flow assays in the food& beverage industry are the growing trends in the global lateral flow assays...RHEA-AIneutral
01/19/23 12:00 PMNasdaq : GTH, TRIB covid-19COVID-19 Pandemic Emphasized the Importance of In Vitro Diagnostics, More than $127 Billion Worth Market Opportunity in the IVD Market - AriztonAccording to Arizton's latest research report, the i n-vitro diagnostics market will grow at a CAGR of 3.3% from 2022-2028. In recent years, IVD diagnostics has been one of the biggest industries that observed several product launches. In 2022, North America accounted for the largest share of 40% of the global IVD market. The patient population with high...RHEA-AIneutral
01/17/23 3:00 PMNasdaq : TRIB low floatThe Evolution of Fourth - Fifth Generation HIV Rapid Test Kits is Booming, the Market to Create USD 2 Billion Opportunities by 2028 - AriztonAccording to Arizton's latest research report, the global HIV rapid test kits market will grow at a CAGR of 2.7% from 2022-2028. HIV rapid test kits have evolved into advanced forms of testing. The application of fourth-generation and fifth-generation rapid test kits is currently high in the market and is expected to become popular in the upcoming years.RHEA-AIpositive
01/12/23 2:30 PMNasdaq : TRIB low floatGlobal Rapid Diagnostics Market Report 2023: Sector to Surpass $77 Billion by 2031 at a 7.4% CAGRThe "Global Rapid Diagnostics Market 2021-2031 by Product, Prescription, Platform, Application, End User, and Region: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com' s offering. Global Rapid Diagnostics market will reach$ 77,095.6 million by 2031, growing by 7.4% annually over 2021-2031, driven by the growing demand...RHEA-AIneutral
01/10/23 9:58 AMNasdaq : TRIB low floatTCC releases 2023 Economic Outlook: Serious risks for U.S. economy as recession loomsSupply chain funding company Trade Capital Corporation today released its 2023 Economic Outlook, warning of a serious risks to the economy as the U.S. appears headed for a recession in 2023, facing, among other risks, inflation and demand compression. TCC makes 20 predictions for the year ahead, including muted growth for U.S. GDP, new opportunities in global...RHEA-AInegative
01/09/23 8:00 AMNasdaq : TRIB partnershiplow floatTrinity Biotech Announces Strategic Partnership with imaware™ to Deliver Integrated Diagnostic Testing Solutions to Digital Health IndustryTrinity Biotech (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, today announced a strategic partnership with imaware Inc that combines their built-to-partnerRHEA-AIvery positive
12/15/22 9:05 AMNasdaq : TRIB earningslow floatTrinity Biotech Announces Q3 2022 Financial ResultsTrinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the Company’s results for the quarter ended September 30, 2022. SummaryRHEA-AIneutral
12/09/22 5:35 AMNasdaq : TRIB earningslow floatTrinity Biotech plc to Announce Third Quarter Fiscal Year 2022 Financial ResultsTrinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financialRHEA-AIneutral
11/30/22 5:50 AMNasdaq : TRIB conferenceslow floatTrinity Biotech to participate in the Piper Sandler 34th Annual Healthcare ConferenceTrinity Biotech (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, is scheduled to participate in the Piper Sandler 34th Annual Healthcare Conference on Thursday,RHEA-AIneutral